Cargando…
Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes
Anti-tumor necrosis factor-α (TNFα) therapy has improved the prognosis of many chronic inflammatory diseases. It appears to be well-tolerated by liver-transplant patients. However, their use and their safety in kidney-transplant patients have yet to be determined. In this retrospective study, we ide...
Autores principales: | Garrouste, Cyril, Anglicheau, Dany, Kamar, Nassim, Bachelier, Claire, Rivalan, Joseph, Pereira, Bruno, Caillard, Sophie, Aniort, Julien, Gatault, Philippe, Soubrier, Martin, Sayegh, Johnny, Colosio, Charlotte, Buisson, Anthony, Thervet, Eric, Bouvier, Nicolas, Heng, Anne Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072954/ https://www.ncbi.nlm.nih.gov/pubmed/27741127 http://dx.doi.org/10.1097/MD.0000000000005108 |
Ejemplares similares
-
Efficacy of rituximab and plasmapharesis in an adult patient with antifactor H autoantibody-associated hemolytic uremic syndrome: A case report and literature review
por: Deville, Clemence, et al.
Publicado: (2016) -
Efficacy of eculizumab in an adult patient with HIV-associated hemolytic uremic syndrome: A case report
por: Freist, Marine, et al.
Publicado: (2017) -
Occurrence of severe COVID-19 in vaccinated transplant patients
por: Caillard, Sophie, et al.
Publicado: (2021) -
Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease
por: Bae, Eunjin, et al.
Publicado: (2017) -
Posttransplantation anemia in kidney transplant recipients: A retrospective cohort study
por: Gafter-Gvili, Anat, et al.
Publicado: (2017)